Biogen, Inc.

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -0.09%704.802.6%$681.87m
AMGNAmgen, Inc. 0.00%230.981.4%$641.11m
MRNAModerna, Inc. -0.70%121.290.0%$629.29m
GILDGilead Sciences, Inc. -0.62%63.531.0%$518.96m
BIIBBiogen, Inc. -2.10%270.801.8%$453.72m
VRTXVertex Pharmaceuticals, Inc. -0.07%292.201.9%$391.06m
ILMNIllumina, Inc. -2.13%197.003.2%$316.82m
SNSSSunesis Pharmaceuticals, Inc. 0.00%4.370.7%$305.48m
SAVACassava Sciences, Inc. -1.51%43.180.0%$192.06m
BNTXBioNTech SE -1.59%131.670.0%$107.99m
NVAXNovavax, Inc. -1.42%19.3375.6%$88.78m
BMRNBioMarin Pharmaceutical, Inc. 0.00%85.844.2%$84.06m
NRBONeuroBo Pharmaceuticals, Inc. 4.20%13.900.0%$80.11m
TECHBio-Techne Corp. 0.00%289.654.5%$75.91m
CRSPCRISPR Therapeutics AG -1.40%66.000.6%$73.92m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.